Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. - Wikidata - wikimedia - TriplyDB

Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.

Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.

http://www.wikidata.org/entity/Q34250392

about

NYSCF-MS-1001-10006-102-Skin-mi-iPSC4 NYSCF-MS-1003-10006-104-Skin-mi-iPSC1 NYSCF-MS-1006-10006-107-Skin-mi-iPSC1 NYSCF-MS-1008-10006-109-Skin-mi-iPSC1

P1343

How to make an oligodendrocyte Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges In vitro myelin formation using embryonic stem cells A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation Induced Stem Cells as a Novel Multiple Sclerosis Therapy Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells Sequential Differentiation of Embryonic Stem Cells into Neural Epithelial-Like Stem Cells and Oligodendrocyte Progenitor Cells Concise review: modeling multiple sclerosis with stem cell biological platforms: toward functional validation of cellular and molecular phenotypes in inflammation-induced neurodegeneration Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes.Defined and Scalable Differentiation of Human Oligodendrocyte Precursors from Pluripotent Stem Cells in a 3D Culture System.Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation.Mesenchymal stem cells and induced pluripotent stem cells as therapies for multiple sclerosis.Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models.Modeling cognition and disease using human glial chimeric mice Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells Oct4-induced oligodendrocyte progenitor cells enhance functional recovery in spinal cord injury model Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells.Maturation and electrophysiological properties of human pluripotent stem cell-derived oligodendrocytes Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.Glial progenitor cell-based treatment of the childhood leukodystrophies.How big is the myelinating orchestra? Cellular diversity within the oligodendrocyte lineage: facts and hypotheses.Human oligodendrocytes in remyelination research.Fluctuations in histone H4 isoforms during cellular reprogramming monitored by middle-down proteomics.Epigenetics in NG2 glia cells.Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.iPSC-based drug screening for Huntington's disease.Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury.Network-Based Genomic Analysis of Human Oligodendrocyte Progenitor Differentiation Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.Targeting human oligodendrocyte progenitors for myelin repair.Pluripotent stem cell-derived radial glia-like cells as stable intermediate for efficient generation of human oligodendrocytes.Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.Myelin repair by transplantation of myelin-forming cells in globoid cell leukodystrophy.Neural Subtype Specification from Human Pluripotent Stem Cells.Cell Therapy for Multiple Sclerosis.Humanized mice: A brief overview on their diverse applications in biomedical research.Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes.

P2860

Q54931451-35F9BF15-0397-4BD5-ADAE-6FF0F7B67335 Q54931453-9476ED25-44F4-4DF6-9A87-05201EA54689 Q54931456-BC49894D-1FB9-4BEB-9207-79557BD8F3B4 Q54931458-CB6D4B18-E853-4C41-9576-102C2E5F8811

P1343

Q26775534-6A47B3BC-3A5A-4EE9-9434-272D8D9BF8B1 Q26780518-2BEE6CA8-3A24-4A3B-B887-73AA08300DAC Q26860309-E7BA9378-CE5B-4259-9F13-B16E1874F9AA Q27345537-6481E006-7C96-4D77-B89D-6184C12EE8A7 Q28078326-F8F44E58-702F-4C2B-8B45-08C1ECF448FA Q28081780-6DB0B912-4E2E-4CBC-B44C-6B13C138EBB8 Q28265816-0F8193E4-7A13-4B87-9B46-62FA210EE441 Q28552130-A084705C-2843-4569-95AF-32F40F57EFA9 Q28649438-E4B5940D-DD58-4D98-B0BA-40BD73C9B4BC Q33559698-6B555CD5-BBFC-476B-A5DA-CFAC47C60385 Q33795348-60967C01-3AD7-427E-A91D-F354DA8C6A7F Q35586144-33D46D4A-F588-4585-9DC2-C753B0AAB5CE Q35722755-D322F819-468D-4B52-BA05-77E5403B3FCB Q35734100-EB91E1B3-E13F-4BB7-8A0E-23B52C66EF20 Q35924207-4BA8E6AC-75BB-4262-B280-B0C6836FBCC7 Q36088126-4CA0FCEB-327C-4BA0-9FF4-714747232A64 Q36278543-5791CB8A-A08F-4E1B-B837-3DB2AD3C24F3 Q36394670-76C6CB2B-7642-414E-A6D7-A963BBF7C991 Q36680149-D18B1993-D15E-4941-9AF5-72B138323820 Q36823991-ADF58ED4-8DAA-402B-9508-4BA89A7105B6 Q37643268-7F19B67B-A7C6-40DA-8B93-551F79232BBB Q37684345-A05F4421-8B10-4BA0-8CE6-7ACD02386373 Q38239642-8E140FB0-1EDF-4061-9E8E-BCF904ACC477 Q38271155-BEFE5108-DE8F-4CF6-8142-2E628C8F2E19 Q38409728-D7B1EA9A-924B-4636-B17E-D9177915EA45 Q38532591-2FFE8BF2-1B84-4ED9-9BF8-60B66A731833 Q38560936-576E3638-64F9-4559-B697-8870580B7728 Q38597179-A85E35D0-F26C-43AF-BD7D-5CF5E65A8615 Q38611681-B0B79D33-75F5-4FF0-8FD2-57379C9C5203 Q38632088-37351D7F-1AB0-4451-BBD5-FCA4BBE9E469 Q38666481-58419CAC-6008-4A3F-8148-A24664793E5E Q38700229-B1B96485-2997-463B-B8C1-756D383A6117 Q38784277-AA515CA8-BE0A-47D3-8DFD-E7DEF955CB0A Q38858842-3A465F28-B3E5-4F86-B089-D7BA77DDBF75 Q38862033-61854BAF-03B7-4CC5-9DD7-0779B38C7A93 Q38936382-B5B932C9-89AE-41D0-A51F-5911D9476804 Q38998787-2A939E6F-5521-422E-B812-643095D784AA Q39233323-BE641744-88BC-408A-9606-71F71D2419EC Q39329450-C39434B0-E65E-4066-9741-536022A290FF Q39825327-DD972F25-72E2-45C3-9F10-9899E9C864D0

P2860

Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.

http://www.wikidata.org/entity/Q34250392

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Efficient generation of myelin ...... nduced pluripotent stem cells.

@ast

Efficient generation of myelin ...... nduced pluripotent stem cells.

@en

Efficient generation of myelin ...... nduced pluripotent stem cells.

@nl

type

label

Efficient generation of myelin ...... nduced pluripotent stem cells.

@ast

Efficient generation of myelin ...... nduced pluripotent stem cells.

@en

Efficient generation of myelin ...... nduced pluripotent stem cells.

@nl

prefLabel

Efficient generation of myelin ...... nduced pluripotent stem cells.

@ast

Efficient generation of myelin ...... nduced pluripotent stem cells.

@en

Efficient generation of myelin ...... nduced pluripotent stem cells.

@nl

P1433

Q34250392-C512C40B-C501-4C89-A1CB-5E0CCBCD4B80

P1476

Q34250392-CC99758F-6FC5-4C1D-90FD-6CD3B4BA0967

P2093

Q34250392-114D49C9-8ECF-460C-8AB6-07AF5A524F3F

Q34250392-21A16CD0-B5B3-4BE1-92EA-A0D440C3C749

Q34250392-2D7819D0-0C87-4342-8309-981923167041

Q34250392-3F687C31-12F9-4104-AE54-7F1CE9988627

Q34250392-56E562AC-C190-4E20-A3E5-49447FFE30AF

Q34250392-60E5D245-3805-4383-9BE0-FBD72897FB75

Q34250392-6A08F689-F087-47B2-AE4D-99CCF7370B47

Q34250392-A0A0DC99-1CB1-4C05-870B-F7913CFBEDDA

P2860

Q34250392-035BF0E5-8AF6-4113-ABED-8F7DF03EA8B6

Q34250392-08B3CFE3-718C-4C1D-BC35-E31BEFDF75E3

Q34250392-0C5E6F05-D5E4-4B65-BBD2-1E43AEE38E79

Q34250392-1745E0C1-89B3-4569-A57D-1116A07668C4

Q34250392-2507267A-B1A2-4C4D-8472-FDA97A25653A

Q34250392-2903D51B-9030-496B-965B-58109E132694

Q34250392-2AC6DD3D-3856-4817-801B-5B8E056785E6

Q34250392-2BCBB135-B68C-4FEE-A24C-FDBA8BE83E9E

Q34250392-37267E7B-8A7D-4B5E-A557-BAF342453052

Q34250392-3E90AE81-D009-46A4-A30E-2D1A2B48C56E

P304

Q34250392-36040E0C-3E17-447F-992D-04551FD02B43

P31

Q34250392-9F015F5E-744A-4DE5-A81F-458C3DCF6F66

P356

Q34250392-3937077F-54DB-43BE-BDB6-315E1A05A46A

P433

Q34250392-7730914E-BDC6-43A6-AFAF-A749415BA740

P4510

Q34250392-278B87CF-636E-4112-BB67-4402945084B4

Q34250392-ACD6621E-A7F3-4FCB-8E5B-88EEEDE3E853

Q34250392-CADAF55D-8391-4B3A-A34D-CB10C6FE16DB

Q34250392-F819E1C7-091B-47DE-B39E-27BD382E7BCE

P478

Q34250392-7E4C3221-2100-4DE0-88F8-DD7E2A4CCCCA

P50

Q34250392-F98BE4F6-B4F8-4DDA-8A91-8B103F6357D6

P577

Q34250392-D9AE42AE-59F2-4D48-95E9-785ED799FD4D

P698

Q34250392-9393E24A-0612-4559-9C29-52DD43DFF06F

P921

Q34250392-47361047-FD6B-4090-A927-863A504286FC

Q34250392-5ACAF4B3-4ABD-496E-9CC3-1BBF5CEE4CD0

Q34250392-8A303E21-C7F9-4D44-A37D-E246A26748E7

Q34250392-8FA9FA5C-4A04-4E44-B2CD-5299AFBC9AB5

Q34250392-D557B98E-1106-4DAC-A720-CA305A494B6F

P932

Q34250392-6AB2955C-00A6-4AE9-A1F5-A118C13571C6

P356

J.STEMCR.2014.06.012

P1433

Stem Cell Reports

P1476

Efficient generation of myelin ...... induced pluripotent stem cells

@en

P2093

Fraser J Sim

http://www.w3.org/2001/XMLSchema#string

James Goldman

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Matthew Zimmer

http://www.w3.org/2001/XMLSchema#string

Melanie A O'Bara

http://www.w3.org/2001/XMLSchema#string

Saud Sadiq

http://www.w3.org/2001/XMLSchema#string

Stephanie Hanchuk

http://www.w3.org/2001/XMLSchema#string

Valentina Fossati

http://www.w3.org/2001/XMLSchema#string

P2860

Human embryonic stem cell-derived oligodendrocytes: protocols and perspectives

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse

Primary progressive multiple sclerosis: progress and challenges.

Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination

Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells.

Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state.

CD140a identifies a population of highly myelinogenic, migration-competent and efficiently engrafting human oligodendrocyte progenitor cells.

P304

250-259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.STEMCR.2014.06.012

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P4510

NYSCF-MS-1001-10006-102-Skin-mi-iPSC4

NYSCF-MS-1003-10006-104-Skin-mi-iPSC1

NYSCF-MS-1006-10006-107-Skin-mi-iPSC1

NYSCF-MS-1008-10006-109-Skin-mi-iPSC1

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Panagiotis Douvaras

P577

2014-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25254339

http://www.w3.org/2001/XMLSchema#string

P921

primary progressive multiple sclerosis

multiple sclerosis

oligodendrocyte

P932

4176529

http://www.w3.org/2001/XMLSchema#string